85 companies

Alnylam Pharmaceuticals

Market Cap: US$43.3b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

ALNY

US$331.91

7D

1.8%

1Y

30.1%

CARsgen Therapeutics Holdings

Market Cap: HK$11.9b

An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.

2171

HK$21.50

7D

-6.9%

1Y

429.6%

Xbrane Biopharma

Market Cap: SEK 380.3m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

XBRANE

SEK 0.25

7D

-3.0%

1Y

12.6%

Ardelyx

Market Cap: US$1.0b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

ARDX

US$4.27

7D

8.9%

1Y

-21.7%

Akeso

Market Cap: HK$101.4b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

9926

HK$113.00

7D

22.9%

1Y

208.3%

Mereo BioPharma Group

Market Cap: US$456.3m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

MREO

US$2.87

7D

5.9%

1Y

-21.8%

Innate Pharma

Market Cap: €140.6m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.

IPH

€1.53

7D

0.3%

1Y

-24.1%

Guard Therapeutics International

Market Cap: SEK 350.9m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.

GUARD

SEK 17.40

7D

1.2%

1Y

-42.0%

Legend Biotech

Market Cap: US$6.6b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

LEGN

US$35.64

7D

0.4%

1Y

-24.8%

Blueprint Medicines

Market Cap: US$8.3b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

BPMC

US$128.35

7D

0.1%

1Y

10.3%

Tenaya Therapeutics

Market Cap: US$99.5m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

TNYA

US$0.61

7D

0.4%

1Y

-79.0%

Capricor Therapeutics

Market Cap: US$468.5m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

CAPR

US$10.25

7D

-8.1%

1Y

113.1%

Vanda Pharmaceuticals

Market Cap: US$292.9m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

VNDA

US$4.97

7D

5.3%

1Y

-5.7%

Soleno Therapeutics

Market Cap: US$4.4b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

SLNO

US$86.65

7D

3.4%

1Y

104.3%

RenovoRx

Market Cap: US$49.7m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

RNXT

US$1.36

7D

6.3%

1Y

19.8%

Abeona Therapeutics

Market Cap: US$301.3m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

ABEO

US$5.89

7D

3.7%

1Y

22.7%

Madrigal Pharmaceuticals

Market Cap: US$6.6b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

MDGL

US$298.87

7D

-1.2%

1Y

2.8%

Aldeyra Therapeutics

Market Cap: US$257.6m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

ALDX

US$4.30

7D

12.3%

1Y

29.9%

ARS Pharmaceuticals

Market Cap: US$1.6b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

SPRY

US$16.52

7D

-5.3%

1Y

74.3%

Achieve Life Sciences

Market Cap: US$112.2m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

ACHV

US$2.18

7D

-3.5%

1Y

-52.4%

OS Therapies

Market Cap: US$54.3m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

OSTX

US$1.83

7D

-2.7%

1Y

n/a

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$80.5b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

6990

HK$352.40

7D

7.7%

1Y

139.7%

Beijing Luzhu Biotechnology

Market Cap: HK$4.4b

A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in China.

2480

HK$22.05

7D

-8.7%

1Y

-3.3%

Oxford Biomedica

Market Cap: UK£355.0m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

OXB

UK£3.35

7D

5.7%

1Y

1.1%

Lipigon Pharmaceuticals

Market Cap: SEK 19.0m

Develops drugs for lipid related diseases in Sweden.

LPGO

SEK 0.13

7D

19.1%

1Y

-58.7%

Aelis Farma

Market Cap: €13.2m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.

AELIS

€0.97

7D

-0.8%

1Y

-92.2%

Precigen

Market Cap: US$478.2m

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

PGEN

US$1.62

7D

14.1%

1Y

4.5%

Arcutis Biotherapeutics

Market Cap: US$1.6b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

ARQT

US$13.82

7D

-1.4%

1Y

32.5%

aTyr Pharma

Market Cap: US$472.6m

A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.

ATYR

US$5.31

7D

4.7%

1Y

247.1%

Kidswell Bio

Market Cap: JP¥10.0b

Develops pharmaceuticals for the treatment of rare and intractable diseases in Japan.

4584

JP¥227.00

7D

-18.6%

1Y

69.4%

Immutep

Market Cap: AU$365.1m

A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.

IMM

AU$0.25

7D

4.2%

1Y

-15.3%

Devyser Diagnostics

Market Cap: SEK 2.2b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

DVYSR

SEK 130.00

7D

2.4%

1Y

17.1%

XOMA Royalty

Market Cap: US$322.6m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

XOMA

US$26.96

7D

7.0%

1Y

9.4%

Invivyd

Market Cap: US$88.2m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.

IVVD

US$0.74

7D

2.8%

1Y

-32.6%

TuHURA Biosciences

Market Cap: US$115.4m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

HURA

US$2.48

7D

11.2%

1Y

n/a

ABL Bio

Market Cap: ₩3.0t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

A298380

₩61,800.00

7D

-8.0%

1Y

113.1%

Page 1 of 3